Editas Medicine Inc
NASDAQ:EDIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HuBei XingFa Chemical Group Co Ltd
SSE:600141
|
CN |
|
Breville Group Ltd
ASX:BRG
|
AU |
|
National Grid PLC
LSE:NG
|
UK |
|
A
|
Ajisen (China) Holdings Ltd
HKEX:538
|
HK |
|
S
|
Secure Income REIT Plc
LSE:SIR
|
UK |
|
Ice Make Refrigeration Ltd
NSE:ICEMAKE
|
IN |
|
Orange SA
NYSE:ORAN
|
FR |
|
P
|
Pacific Industries Ltd
BSE:523483
|
IN |
During the last 3 months Editas Medicine Inc insiders have not bought any shares, and sold 13.4k USD worth of shares. The stock price has increased by 38% over this period (open performance analysis).
The last transaction was made on
Mar 3, 2026
by
Burkly Linda
, who
sold
1.5k USD
worth of 
EDIT shares.
During the last 3 months Editas Medicine Inc insiders have not bought any shares, and sold 13.4k USD worth of shares. The stock price has increased by 38% over this period (open performance analysis).
The last transaction was made on
Mar 3, 2026
by
Burkly Linda
, who
sold
1.5k USD
worth of EDIT shares.
Editas Medicine Inc
Glance View
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. The company is headquartered in Cambridge, Massachusetts and currently employs 264 full-time employees. The company went IPO on 2016-02-03. The firm is focused on developing transformative gene editing medicines to treat a range of serious diseases. The company has developed a gene editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The firm is focused on both in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, and ex vivo gene-edited cell medicines, in which cells are edited with its technology. The firm's gene editing medicine programs include EDIT-101, EDIT-102, EDIT-103, EDIT-301 and EDIT-202.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
